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Available online 25 May 2005BOLD contrast is the most commonly used functional MRI method for
studies of brain activity. However, the underlying physiological
processes giving rise to measured BOLD signal changes (which include
contribution from changes in cerebral blood flow (CBF), cerebral blood
volume (CBV) and cerebral metabolic rate of oxygen consumption
(CMRO2)) vary substantially between sessions and subjects. To
determine whether direct CBF measurement is a more reliable
technique, we compared the localisation of activation and reproduci-
bility of relative signal change measured by optimised BOLD versus
CBF measured using the arterial spin labelling (ASL) technique. Data
were collected within the primary sensorimotor cortex in normal
healthy controls performing a simple finger-tapping task over three
imaging sessions (two on same day and one on a different day). The
displacement between the foci of BOLD and CBF activation was less
than the linear dimension of one voxel (2.4 mm), however, BOLD
activation was significantly closer to the nearest draining vein
compared to CBF activation (P = 0.030). For the relative signal change
measurement, we found that CBF has a lower inter-subject variation
than BOLD (P < 0.05), enabling a smaller sample size for any given
effect size, although the intra-subject variation across sessions for CBF
was not significantly different from BOLD. BOLD imaging provides
the optimal contrast for exploratory brain activation mapping,
however, for a single time-point group study, CBF has reduced
variance. In addition, the reduction of variance over time using CBF
measurements (non-significant) suggests it could potentially provide a
more useful approach when assessing longitudinal activation changes.
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Functional magnetic resonance imaging (FMRI) has been used
to detect human brain activity changes associated with motor,
sensory or cognitive processes. Since its first application over 10
years ago to detect human brain areas processing vision, it has been
applied widely to study normal human brain function (Bandettini et
al., 1992; Belliveau et al., 1991; Kwong et al., 1992; Ogawa et al.,
1993). There has been a growing interest in using FMRI for
clinical studies of the brain (see Matthews and Jezzard, 2004 for a
review) and, in particular, for longitudinal studies of patients to
monitor either disease progression or therapeutic intervention
(Johansen-Berg et al., 2002; Kumari et al., 2002). The combination
of FMRI with administration of central nervous system (CNS)
acting drugs provides a powerful opportunity to determine site and
efficacy of drug action in the human brain (Rogers et al., 2004;
Tracey, 2001; Wise et al., 2002, 2004).
Despite its popularity, there are potential problems with the
commonly applied BOLD functional imaging in these applications.
First, the signal change can vary substantially between subjects and
across sessions (Aguirre et al., 1998; McGonigle et al., 2000). This
variability reduces the statistical power in longitudinal design.
Secondly, in many studies, it has been noted that the signal within a
brain active region varies widely between individuals for reasons
that are poorly understood (Miezin et al., 2000; Rajapakse et al.,
1998), which again limits the applicability of this method in patient
and drug studies. A third problem with FMRI is that the exact
location of signal change may not define exactly where the
presynaptic neuronal activity is found (Logothetis et al., 2001).
This is because a joint measure of changes associated with the
cerebral blood flow (CBF), cerebral blood volume (CBV) and the
cerebral metabolic rate of oxygen consumption (CMRO2) is being
assumed to produce contrast in BOLD FMRI. The complex
interactions of these underlying mechanisms make changes in the
BOLD signal difficult to interpret.
T. Tjandra et al. / NeuroImage 27 (2005) 393–401394Direct CBF measurements using MRI provide an attractive
alternative. Recent studies have compared BOLD with CBF
measurement using the arterial spin labelling perfusion imaging
technique (Aguirre et al., 2002; Luh et al., 2000; Wang et al.,
2003a,b; Yang et al., 1998). Such reports suggest that CBF
measurement provides improved sensitivity relative to BOLD
particularly for low-frequency tasks and is associated with lower
inter-subject variability (Aguirre et al., 2002; Wang et al., 2003a).
However, such studies (with the exception of Wang et al., 2003a)
were performed using non-optimised BOLD acquired simulta-
neously with the ASL technique.
Here, we investigate further both the intra- and inter-subject
group variability of the two modalities for a simple motor hand-
tapping task using three separate analyses. A first analysis
explored the location of activation for BOLD and CBF within
the primary sensorimotor (PSM) area and compared the Euclidean
distance relative to the small draining vein defined using an MR
venogram (Reichenbach and Haacke, 2001). Next, we assessed
the reproducibility of the intra-subject variation of the relative
signal change arising from motor activity measured by BOLD and
CBF across three sessions (two same day, one different day)
within three separate pre-defined regions of interest: the entire
PSM and separate anatomically defined primary motor (M1) and
primary sensory (S1) cortices. Within these regions, we also
measured the inter-subject variation of the relative signal change
for the group between BOLD and CBF. Finally, we investigated
the reliability of each modality based on a retrospective power
calculation for the sample size required to produce a given
statistical significance. This work extends the current under-
standing of the variability of the signal change measured by
BOLD and CBF and allows more accurate estimation of the
sample sizes required (Fig. 1).Fig. 1. A schematic diagram for the assessment of the reproducibility of the re
hand-tapping experiment for n = 5 in k = 3 sessions (two within same day, one
day_ and Facross all sessions_ experimental comparisons was each measured as t
sessions #1 and #2 on Day 1, (ii) between sessions #1 and #3 and (iii) all three
separated by a one-week interval. For the inter-subject variability analysis, the
relative signal change for each session was normalised to the subject_s average v
these normalised relative signal changes for the pooled data was calculated for bo
using an F-test.Materials and methods
Subjects
6 normal right-handed subjects (age, 26.2 T 4.2, three male)
were recruited. They performed a visually cued four-finger-tapping
experiment using the right hand in a block-design paradigm
consisting of 8 cycles of 20 s OFF (resting) and 32 s ON (active)
periods at a frequency of 2 Hz. Each subject had their right four
fingers taped together for one synchronous hand-tapping move-
ment whilst maintaining the thumb and wrist stationary with a hand
brace. An in-house built wooden brace was designed with a
horizontal wooden bar pegged across the edges at the back of the
device, 3 cm high from the base. In use, the palm of the hand rested
on the base, and the fingers touched the wooden bar for each tap.
This kept the amplitude and angle of the tapping motion from the
base constant for all subjects in each scan. Each subject was told to
minimise any limb movement. Head motion was minimised
through the use of restraints such as padding on both sides of
the temples with tape across the forehead. Each subject repeated
the experiment three times: two sessions performed within the
same day separated by a 30-min break outside the scanner and the
third on a separate day 1 week later. All subjects were requested to
refrain from caffeinated drinks 3 h before each study, as caffeine
could cause an overall increase in the BOLD contrast during
activation (Mulderink et al., 2002).
MR scanning
Imaging was performed on a 3 T Varian/Siemens MRI scanner.
BOLD FMRI was acquired first using a single-shot gradient-echo
(GRE) echo-planar imaging (EPI) sequence (208 volumes plus 4lative signal change measured by BOLD and CBF modalities in a motor
on a different day). The intra-subject variability for Fsame-day,_ Fbetween-
he coefficient of variation (CV) of the relative signal change: (i) between
sessions, respectively. Note that in our experiment, Day 1 and Day 2 is
pooled data was collated (5 subjects  3 sessions = 15 data-sets). The
alue of the relative signal change across all three sessions. The variance of
th BOLD and CBF and their results compared for significant difference by
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ratio (SNR), flip angle = 75-, 21 contiguous axial slices of 6 mm
thickness parallel to the anterior–posterior commissure (AC–PC),
covering the whole brain from the base of the cerebellum to the
vertex, FOV = 256  256 mm2, matrix = 64  64). Subsequently
and in the same imaging session, perfusion data were acquired
using Pulsed Arterial Spin Labelling (PASL) technique with
QUIPSS-II (Quantitative Imaging of Perfusion using a Single
Subtraction) method (Wong et al., 1997, 1998a,b). An adiabatic
inversion pulse was employed for labelling followed by optimised
inversion time delays TI1 = 700 ms and TI2 = 1500 ms, chosen so
as to minimise the flow-through effect whilst allowing sufficient
SNR (Luh et al., 2000; Wong et al., 1998a,b). Interleaved tag and
control images were acquired using a GRE-EPI sequence, with
acquisition parameters: TR/TE = 2000/20 ms and flip angle = 75-.
The imaging region consisted of 5 contiguous axial slices of 6
mm thickness acquired parallel to the AC–PC line from the
vertex of the brain. This encompassed the primary motor area
based on an anatomical observation from the Fomega_ landmark
on the axial plane and the Fhook_ shape identified on the sagittal
view (Yousry et al., 1997). The imaging slab with FOV = 256 
256 mm2 and matrix = 64  64 was separated by a 15-mm
spacing from the 100-mm-thick inversion slab. A 5-slice volume
of the equilibrium brain tissue magnetisation, M0, was acquired to
normalise the difference perfusion maps using the same sequence
parameters as mentioned above for QUIPSS-II. A 21-slice volume
of the equilibrium magnetisation of the whole brain was acquired
as a reference image for subsequent registration from 5 slices to
21 slices.
During one of the three separate imaging sessions, a high-
resolution whole brain structural scan was acquired for each
subject using a T1-weighted sequence inversion recovery (IR) 3D
Turbo FLASH (TR/TE = 30/5 ms, TI = 500 ms, flip angle = 20-,
64  3 mm axial slices parallel to the AC–PC plane, FOV = 256 
256 mm2, matrix = 256  256). In addition, an MR venogram was
acquired to define the location of small veins in the sub-millimetre
range within the region of interest for each subject using a T2*-
weighted Turbo Echo sequence. This technique utilises the
differences in magnetic susceptibility between deoxyhaemoglobin
in venous blood (as an intrinsic contrast agent) and the
surrounding tissue to generate contrast (Reichenbach and Haacke,
2001). The acquisition parameters were: TR/TE = 40/30 ms, flip
angle = 30-, 64 slices of 2 mm thickness covering the whole brain
from the base to the vertex parallel to the AC–PC line, FOV =
256  160 mm2, matrix = 512  384 for a 0.5  0.4  2 mm3
resolution.
Image analysis
Analysis was carried out using FEAT (FMRI Expert Analysis
Tool) Version 5.1, part of FSL (FMRIB’s Software Library, http://
www.fmrib.ox.ac.uk/fsl). The following pre-statistics processing
was applied for BOLD FMRI data; motion correction using
MCFLIRT (Jenkinson and Smith, 2002); spatial smoothing using
an ‘‘optimum’’ Gaussian kernel of full width half maximum
(FWHM) 5 mm (Ye et al., 1997); mean-based intensity normal-
isation of all volumes by the same factor; high-pass temporal
filtering (Gaussian-weighted LSF straight line fitting, with j =
39.0 s). Time-series statistical analysis was carried out using
FILM (FMRIB’s Improved Linear Model) with local autocorre-
lation correction (Woolrich et al., 2001). For intra-subject analysis,the Z (Gaussianised T/F) statistic images for each subject were
thresholded using clusters determined by Z > 2.3 and a (corrected)
cluster significance threshold of P < 0.01 (Friston et al., 1994;
Forman et al., 1995; Worsley et al., 1992) with a requirement of at
least four contiguous voxels. Random effects group analyses for
BOLD and CBF for the group Z statistic images were thresholded
using Z > 1.8 and a cluster significance threshold of P < 0.05,
corrected for multiple comparisons (Forman et al., 1995), to take
into account the low SNR in CBF and a small sample size.
Registration to individual high-resolution structural images and
the MNI (Montreal Neurological Institute) standard brain (Collins
et al., 1994) was carried out using FLIRT (FMRIB’s Linear Image
Registration Tool) (Jenkinson and Smith, 2002) using 9 and 12
degrees of freedom (DOF) respectively.
Perfusion maps were calculated by pair-wise subtraction of the
time-matched tag and control images, normalised by the equili-
brium brain tissue magnetisation, as described by Wong et al.
(1997). The pre-statistics processing and the post-processing
statistical significance based on clustering applied to perfusion
images were the same as BOLD for both intra-subject and within-
group analyses (except for no prewhitening correction of CBF data
since there is no significant temporal autocorrelation compared to
BOLD data (Wang et al., 2003b)). The registration from 5 slices to
21 slices (i.e. CBF to BOLD) was performed with FLIRT using 3
DOF before further transformation to the high-resolution structural
and MNI standard brain using 12 DOF.Data analysis
Regions of interest (ROIs) were defined within the correspond-
ing (i.e. contralateral) hemisphere of each individual’s high-
resolution T1-weighted structural image using the anatomical
landmark (omega shape) in axial plane (Yousry et al., 1997).
Anatomical masks for three regions of interest (ROI) within each
subject were defined as: (a) the primary motor cortex (M1; the
posterior half of the precentral gyrus, corresponding to Brodmann
area 4), (b) the primary sensory cortex (S1; the postcentral gyrus,
corresponding to Brodmann areas 3, 1 and 2) and (c) the primary
sensorimotor cortex (PSM), which is the sum of both M1 and S1.
For each subject, the ROI extended on the lateral surface of the
cortex to the midline and from the vertex of the brain to the level of
the superior aspect of the lateral ventricles caudally. The PSM
mask excludes the gap of the central sulcus separating the anterior
bank of S1 and the posterior bank of M1.
Each anatomical mask was used to calculate the mean signal
change for the hand-tapping activation. For calculation of the
location of activation, only the PSM mask was used. For this, we
proposed using the centre of gravity (COG) measurement
technique which is the weighted (by signal change) location of
the centre of activation within a cluster volume of neighbouring
voxels that are significantly activated.
Group analysis was conducted for all subjects in each session
for each modality to find the degree of overlap between sessions
and to determine the extent of the activation within primary
sensorimotor cortex (PSM). The MNI coordinates were noted for
the PSM area and were compared as a reference for intra-subject
analyses for the location of activation. In addition, a frequency map
was computed: this was defined as the overlay of group activation
in which the thresholded Z score map from each session was
binarised and superimposed in order to illustrate the common area
Fig. 2. The frequency map of the group thresholded Z-score image for all three sessions were superimposed on one another for BOLD (left column) and CBF
(right column) in axial, coronal and sagittal views. Each frequency map is colour coded using blue, yellow and red to represent the overlap of one, two and
three sessions to show the difference in the spatial extent of the functional activation for BOLD and CBF for the primary sensorimotor cortex with respect to
different sessions. A Z-score image of the BOLD and CBF activation in one subject is also shown on the bottom right corner respectively.
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between BOLD and CBF (see Fig. 2).
Testing for the variability of the location of activation
To test if BOLD and CBF co-localise, the displacement of the
location of activation from CBF to BOLD for each session in each
subject was calculated in terms of the Cartesian X-Y-Z coordinates
from the COG measurement within each anatomical mask. The
mean displacement across the group was calculated. A draining
vein was used as a second reference point to measure the relative
displacement and distance for each modality. The rationale was to
determine whether BOLD activation is closer to large vessels
compared to CBF activation. Each draining vein was defined for
each subject as the estimate of the nearest vein to the motor hand
area (see Fig. 3). The displacement with respect to the draining
vein was calculated for each subject in all three sessions for each
coordinate. The group mean Euclidean distance for BOLD and
CBF was compared using a two-tailed paired t test.Fig. 3. The small draining vein (red) defined for one subject and overlaid onto th
structural (right). The course of the small vessel was observed from the venogram
closest to the motor hand area is chosen as the reference point (green cross-linesThe reproducibility of the signal change within each ROI
Fig. 2 shows a schematic diagram for the assessment of the
reproducibility of the signal change measurement for BOLD and
CBF. The mean signal changes over all sessions were determined
for both BOLD and CBF in each ROI. The variance from the pooled
data (5 subjects  3 sessions = 15 data-sets) for each modality was
calculated (Var = ~(xi  xavg)2 / (N  1)) in each ROI. This
variance for BOLD and CBF measurements was compared using
an F-to-p ratio of variance test (F = larger Var / smaller Var) to
test for any significant difference in the inter-subject variability of
the measured relative signal change. For the purpose of normal-
isation in this pooled variance calculation, the signal change
measured from each session for each subject was subtracted
followed by division from the respective individual’s average
signal change across sessions (see Fig. 1). This allows adjustment
for the difference in magnitude between BOLD (in the order of
1–2%) and CBF (in the order of 30–40%) signal change
measurements.e subject_s venogram map (left) compared to the overlay on the anatomical
map over 5 slices axially, coronally and sagittally. The point of draning vein
).
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subject reproducibility for each ROI in three experimental
comparisons: (1) all three sessions, (2) two sessions from the
same day and (3) two sessions between different days. For the
latter between-day comparison, we used the first session on each
day. Each subject’s CV was defined as the standard deviation of the
task-related signal change across sessions divided by the mean of
the task-related signal change across sessions for each comparison
in each ROI.
CV ¼ ri=xavg
 
T 100%ð Þ; where rˆi ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiX ðxi  x¯ Þ2
n 1
s
and n ¼ number of sessions compared
The group means for this intra-subject CV measurement were
calculated for each experimental comparison, and the results for
BOLD and CBF were compared with two-tailed paired t tests for
each ROI to test for any significant difference in the intra-subject
CV across the group. The standard deviation of this CV measure-
ment for BOLD and CBF was calculated. These values were
compared between the two modalities for each of the above-
mentioned experimental comparisons using an F test. This tested
for any significant difference in the variability of the intra-subject
variation within the study group.
In addition, to further interrogate the source of variation and
assess whether common components contribute to the variance in
BOLD and CBF, the pooled data for the signal change measure-
ment for BOLD were tested for any significant correlation with that
for CBF within each ROI using a Pearson correlation.
Testing for the required sample size for different effect sizes
To assess the utility of both modalities, a retrospective power
calculation was done to compare the number of subjects needed to
detect statistically significant 10%, 20% and 30% signal difference
or experimental ‘‘effect size’’ (null hypothesis was zero activation)
using the inter-subject variance across all sessions within the
PSM. The sample size was estimated using MacANOVA softwareTable 1
Results for the analysis of the location of activation for BOLD and CBF measur
Subject Draining vein
coordinates (X, Y, Z)
Average BOLD
location across
sessions*
(X, Y, Z)
Average CBF
location acros
sessions*
(X, Y, Z)
1 42.7 27.9 58.3 43.0 23.1 55.1 40.9 24.7
2 29.2 14.4 61.0 38.1 11.9 57.3 40.3 13.5
3 31.1 36.2 64.3 40.1 32.7 60.5 37.8 33.4
4 43.8 23.9 54.6 42.9 28.7 56.4 36.1 26.0
5 38.9 20.6 49.7 40.2 18.9 56.8 38.3 19.4
Group
mean (SD)
37.1
(6.7)
24.6
(8.2)
57.6
(5.7)
40.9
(2.1)
23.0
(8.2)
57.2
(2.0)
38.7
(2.0)
23.4
(7.4)
Data for the location of the draining vein nearest to the primary sensorimotor co
shown for each subject in terms of the X,Y, Z coordinates (the first 4 columns). Ea
of activation for BOLD and CBF shown for each subject is the average across a
significant cluster within PSM with threshold of Z > 2.3, P < 0.01. The next 4 colum
respective Euclidean distance, with respect to the draining vein. The group mean
millimeter.
* Note for simplicity, the standard deviation for each subject across sessions for
testing of significant difference in the displacement and distance between BOLD
group (not shown here) was used.for a single-sample two-tailed t test (http://www.stat.umn.edu/
macanova).
For all tests described above, significance was accepted if
P < 0.05.Results
Full data-sets obtained from 5 subjects are reported. The sixth
subject was considered an outlier since the signal change measured
for BOLD was at least 2 standard deviations smaller than the group
average for two out of three sessions.
Variability in the localisation of activation changes
The group mean vector averaged across sessions showed only a
small and non-significant displacement between CBF and BOLD
measurements: X = 2.2 T 3.2 mm; Y = 0.4 T 1.8 mm; Z = 0.1 T
4.5 mm (Table 1). However, the group mean Euclidean distance to
the nearest draining vein for BOLD (7.8 T 2.3 mm) was
significantly smaller compared to CBF (10.2 T 3.5 mm) (t =
2.409, P = 0.030, two-tailed) (Fig. 4).
Reproducibility of signal change
Table 2 summarises the results of the group average of the
pooled signal change measurement for all subjects and all sessions,
the pooled variance of this measurement and the group mean of
intra-subject CV across sessions and day difference for BOLD and
CBF in three regions of interest (ROI). Fig. 5 illustrates the mean
signal change across sessions for each subject in each ROI, whilst
Fig. 6 illustrates the group mean CV and the standard deviation for
comparisons across all-sessions, within the same day and between
days in each ROI.
The group mean signal change in the primary sensorimotor
cortex (PSM) for BOLD was 1.23 T 0.34% whilst that for CBF was
40.55 T 5.24%. There was a significantly lower pooled variance for
CBF measurement (0.012) than for BOLD measurement (0.032)ed by the centre of gravity (COG)
s
With respect to the draining vein
BOLD
displacement*
(X, Y, Z)
CBF
displacement*
(X, Y, Z)
BOLD
distance
CBF
distance
54.3 0.3 4.8 3.2 1.8 3.2 4.0 6.0 6.2
50.4 8.9 2.5 3.7 11.1 0.9 10.6 10.0 15.6
60.7 9.0 3.5 3.8 6.7 2.8 3.6 10.5 8.3
61.7 0.9 4.8 1.8 7.7 2.1 7.1 5.2 11.2
59.2 1.3 1.7 7.1 0.6 1.2 9.5 7.4 10.0
57.3
(4.8)
3.7
(4.8)
1.6
(3.7)
0.4
(4.8)
1.5
(7.4)
1.2
(2.1)
0.3
(8.4)
7.8
(2.3)
10.2
(3.5)
rtex (PSM) and the respective BOLD and CBF location of activation was
ch draining vein was defined using an MR venogram. The average location
ll three sessions and was calculated from the centre of gravity (COG) of a
ns show the displacement of BOLD and CBF location of activation and the
T standard deviation (SD) for each column is also shown. All units are in
the COG measurement (the location and the distance) is not shown. For the
and CBF, the pooled data (i.e. each individual data for all sessions) for the
Fig. 4. A plot of the motor-hand tapping activation pattern (Z-score activation map; 2.3  Z  5) seen in BOLD and CBF modalities for Subject #4 in session
#2, overlaid onto the subject_s structural image. The respective localisation of BOLD and CBF activation measured by the weighted centre of gravity (COG)
metric (see green square) was shown within the primary sensorimotor cortex (PSM) region-of-interest relative to the draining vein (see blue square), as defined
by the MRVenogram as a small dark circle closest to the Fomega_ shape. This example illustrates the fact that BOLD COG is closer to the draining vein than
that for CBF.
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of the intra-subject CV measurement across all sessions for BOLD
was 17 T 14% (range: 2–39%), whilst that for CBF was 13 T 3%
(range: 9% to 17%) (see Table 2 and Fig. 6). The standard
deviation of this CV measurement for BOLD was significantly
greater than for CBF for all experimental comparisons (F tests,
P < 0.05) (Fig. 6). The relative signal changes of the pooled
data within PSM for BOLD (1.23 T 0.34%) showed a trend
towards a positive correlation with those for CBF (40.55 T 5.24%)
(r = 0.498, P = 0.059).
Considering the sub-regions of PSM separately, the group mean
signal change in the primary motor cortex (M1) across all sessions
for BOLD was 1.39 T 0.91%, whilst for CBF it was 42.89 T 9.65%.
There was a significantly lower pooled variance for CBF measure-
ment (0.015) than for BOLD measurement (0.063) (F1,14 = 4.20 at
P = 0.01; see Table 2 and Fig. 5). The group mean of the intra-
subject CV measurement across all sessions for BOLD was 24 T
19% (range: 5–55%), whilst that for CBF was 14 T 6% (range: 4–
20%) (see Table 2 and Fig. 6). The standard deviation of this CV
measurement for BOLD was significantly greater than CBF for
Facross all sessions_ experimental comparison (F test, P < 0.05)
(see Fig. 6). The relative signal changes of the pooled data withinTable 2
Results for the analysis of the reproducibility of signal changes for BOLD and C
Region of interest PSM ROI M1 R
Modality BOLD CBF BOLD
A. Group average
of the mean signal
change T SD (%)
1.23 T 0.39 40.55 T 6.72 1.39
B. Pooled variance 0.032 T 0.025 0.012 T 0.006 0.063
C. F ratio: BOLD vs.
CBF
2.67* 4.20*
D. Mean CV T SD (%)
1). All sessions
17 T 14 13 T 3 24
2). Same day 15 T 18 14 T 3 18
3). Different days 21 T 15 4 T 2 20
Results of the reproducibility analysis for BOLD and CBF measurement in each re
the mean signal change (%) T standard deviation (SD) across subjects for three se
variance between BOLD and CBF, (D) The mean Coefficient of Variation, CV for
the same day, and (3) two sessions in different days are also shown. Note that * dM1 for BOLD showed a significant positive correlation with those
for CBF (r = 0.566, P = 0.028).
The group mean signal change in the primary somatosensory
cortex (S1) across all sessions for BOLD was 1.19 T 0.55%, whilst
that for CBF was 39.52 T 4.10%. There was a trend towards a
significant difference for the pooled variance between BOLD and
CBF measurements; BOLD having greater variability (0.064) than
CBF (0.029) (F test P = 0.07; see Table 2 and Fig. 5). The group
mean of the intra-subject CV measurement across all sessions for
BOLD was 24 T 20% (range: 2–44%), whilst that for CBF was
16 T 5% (range: 10–21%) (see Table 2 and Fig. 6). Within S1, the
standard deviation of this CV measurement for BOLD was
significantly greater than CBF for all experimental comparisons
(F test s, P < 0.05) (see Fig. 6). The relative signal changes of the
pooled data within S1 for BOLD did not show any significant
correlation with that for CBF.
Implications for sample size calculation
Table 3 shows the required sample size using the retrospective
power calculation to detect different effect sizes and was obtained
using the information from the pooled variances of the signalBF
OI S1 ROI
CBF BOLD CBF
T 0.91 42.89 T 10.51 1.19 T 0.56 39.52 T 6.88
T 0.035 0.015 T 0.005 0.064 T 0.050 0.029 T 0.022
* 2.21
T 19 14 T 6 24 T 20 16 T 5
T 13 13 T 8 18 T 18 14 T 4
T 20 11 T 10 30 T 25 10 T 5
gion of interest (ROI): PSM, M1 and S separately: (A) The group average of
ssions, (B) The pooled variance (T error), (C) The F ratio test of the pooled
the group for each comparison: (1) all three sessions, (2) two sessions within
enotes significance at P = 0.05 while ** denotes significance at P = 0.01.
Fig. 5. A plot of the mean signal change (%) average across three session for each subject for BOLD (left) and CBF (right) measurement within three regions of
interest: primary sensorimotor (PSM), primary motor (M1) and primary sensory (S1) cortices. Error bars denote one standard deviation.
T. Tjandra et al. / NeuroImage 27 (2005) 393–401 399change measurement in PSM. We estimate that CBF-based FMRI
should require fewer subjects than BOLD to detect a similar
change over time.Discussion
We have investigated the reproducibility and reliability of the
BOLD signal change and CBF measurement during a simple finger
movement task. Motor activation was found within contralateral
primary sensorimotor cortex (PSM) for all subjects in each session.
The group activation map showed a larger area of BOLD activation
for all sessions compared to CBF (see Fig. 2), reflecting the
superior sensitivity of BOLD compared to ASL. The average
common area of overlap for CBF group activation across sessions
(¨60%) is larger than for BOLD (¨40%). As the statistical
threshold changes for determining BOLD activation, it is expected
that the relative percentage of overlap between CBF and BOLD
will change. However, as this is not the main objective of our
study, we have not investigated this relationship further.
By focussing on activation in the primary sensorimotor cortex,
we have demonstrated that small spatial differences in the
activations centres of gravity (COG) may be detected between
CBF and BOLD. The first part of our analyses shows only minor
spatial differences in the activation measured from the centre of
gravity (COG) between CBF and BOLD with activation in the
primary sensorimotor cortex. However, we found that BOLDFig. 6. A plot of the group mean Coefficient of Variation (CV) for each experiment
different days; within three regions of interest; primary sensorimotor (PSM), prima
(right). Error bars denote one standard deviation of the group mean CV. * denotes a
for a given comparison between BOLD and CBF in a given region of interest (foactivation was significantly closer to the draining vein compared to
CBF. This supports the notion that CBF may more accurately
localise brain activation due to its greater sensitivity to changes in
the capillary bed local to the activated neuronal population (Lee et
al., 1999; Talagala and Noll, 1998; Wong et al., 1997) than the
venule side–as is the case for BOLD contrast.
The inter-subject variability for CBF changes was significantly
lower than for BOLD changes, which was reflected in the smaller
pooled variance (see Table 2 and Fig. 5). The group mean CV for
BOLD intra-subject variability was greater than that for CBF (see
Table 2), although this could not be demonstrated significantly for
each specific serial quantitative assessments (Facross all three
sessions_, Ftwo sessions on the same day_ or Ftwo sessions on
different days_) presumably due to the small sample size. There
was a significant degree of variability in this intra-subject variation
within the group (see Fig. 5). CBF had significantly lower
variability than BOLD for all experimental comparisons in PSM
and S1, as well as for Facross all three sessions_ experimental
comparison in the M1 region. This is because of the lower standard
deviation for the group mean CV measurements in CBF compared
to BOLD (see Table 2 and Fig. 6). BOLD shows particularly
greater variability of this intra-subject variation than CBF for
Fsessions on different days_ experimental comparison since the
95% confidence interval for the paired t tests has a wider range in
each region of interest (data not shown) compared to the sessions
Fon the same day_ and Facross all three sessions_. These
observations have important implications for the design of clinicalal comparison: 1) across all sessions, 2) within the same day and 3) between
ry motor (M1) and primary sensory (S1) cortices for BOLD (left) and CBF
significant difference between the standard deviation of the group mean CV
r clarity, significant differences are shown on both BOLD and CBF data).
Table 3
Results for the calculation of the sample size (T error) for BOLD and CBF
measurements for each given effect size
Modality Pooled
variance
Sample size for an effect size
10% 20% 30%
BOLD 0.032 28 T 22 9 T 8 6 T 5
CBF 0.012 12 T 7 5 T 4 4 T 3
A summary of the results for the sample size calculation (T error) for BOLD
and CBF with effect sizes 10%, 20% and 30%, standardised using the
pooled variance of the signal change measurement across all three sessions
and five subjects within the primary sensorimotor cortex. The test for each
modality is for a single-sample two-tailed test with alpha = 0.05 and power =
0.80.
T. Tjandra et al. / NeuroImage 27 (2005) 393–401400research in which serial observations are to be compared. It is
apparent from the power calculation in Table 3 that CBF allows
more efficient trial design than BOLD.
Our results extend the observation (Aguirre et al., 2002; Wang
et al., 2003b) showing that CBF gives significantly lower inter-
subject variability (see Fig. 6). In addition, we demonstrated a
trend for CBF to have lower intra-subject variability for sessions
performed on the same day, different days and across all sessions.
CBF measurement of the relative signal changes is also more
consistent (reproducible) across different subcortical areas of motor
hand area; the primary sensorimotor cortex and the primary
sensory cortex, with a trend towards significance for the primary
motor cortex. The greater inter-subject variability of BOLD
measurements across sessions could be a consequence of multiple
factors (e.g. CBF, CBV and CMRO2) contributing to its changes.
This also includes differences in biological causes such as
hormonal changes, arterial concentration of CO2 and haematocrit.
The reduced intra-subject variability in CBF compared to BOLD
could also be due to the inherent subtraction of label and control
images in the ASL measurement which gives a more stable
baseline than BOLD.
Our results for the correlation analyses show that common
components of BOLD and CBF measurement contribute to the
variances determined. However, differences in the BOLD and CBF
correlation measurements were found between M1 and S1. This
could be due to the differences in the underlying neuronal
activation, and interestingly a recent study examining differences
between the haemodynamic response for BOLD and CBF across
M1 and supplementary motor area (SMA) has also shown
correlation differences between these regions (Obata et al.,
2004). Obata and colleagues found that the average BOLD
response from the beginning to the end of the motor task was
different between M1 and SMA, whilst CBF responses in the two
regions were similar.
Despite this, the evidence for greater accuracy of localisation
with CBF is less conclusive. Firstly, the group standard deviation
for the CBF Euclidean distance relative to the draining vein is
greater than BOLD (Table 1). This is likely due to the relatively
low SNR of our CBF measurements. Secondly, the difference in
the group mean Euclidean distance (t = 2.4 mm) between the two
modalities is within the inherent resolution of collected data (4 4
6 mm3) and the high-resolution structural space to which it was
registered (1  1  3 mm3). The difference could be due at least in
part to registration problems during transformation from functional
to structural space. However, this difference in the distance
measured for BOLD and CBF relative to the draining vein is within
5 voxels of the inherent resolution of the venogram (0.5  0.4  2mm3) from which the draining vein for each subject was depicted.
This finding could partially be explained by the fact that we used a
gradient-echo (GRE) EPI sequence which is known to suffer from an
increased sensitivity to venous contributions (Duong et al., 2003;
Zhao et al., 2004). Our reason for choosing this sequence, which
potentially biases our result, is because it has a higher SNR as
compared to a spin-echo (SE) EPI sequence.
Nevertheless, it still cannot be inferred from our data that CBF is
potentially more co-localised to neuronal activation, as activation
may be shifted towards the feeding artery rather than the capillary
site, although there is no literature to support that this occurs. It is
known, however, that venous drainage can extend as far as a few
centimetres away from the capillary, therefore a potentially larger
concern for BOLD than CBF. A potential direction to explore this
disparity in displacement would be to use a more precise electro-
physiological method as an independent measure of neuronal
activity for comparison between BOLD and CBF localisation of
activation. A study performed by Disbrow et al. (2001) had found
that BOLD activation was weighted towards the draining vein
within the central sulcus of the motor area in monkeys, compared to
the recorded electrical potentials, which presumably reflect the site
of neuronal activity. In addition, other work has shown that CBF is
perhaps a better prescriptor of the neuronal activity (Lee et al.,
1999). Studies on spatial specificity at sub-millimetre resolution
have shown that perfusion-based FMRI can be used to map
individual functional columns provided that large-vessel contam-
inations are minimised or eliminated (Duong et al., 2001). Further
investigations are clearly needed to prove unequivocally that CBF
provides a more reliable marker for the location of brain activation
such that one could use it for determining healthy tissue margins
during pre-surgical planning for brain tumour resection.
In conclusion, although BOLD imaging gives a high signal-to-
noise ratio (SNR) for studies of activation, perfusion (CBF)
measurements in PSM show significantly lower inter-subject
variability. This enables a smaller sample size for CBF-based
studies compared to BOLD studies to detect any given effect size.
CBF also has a trend for lower intra-subject variability when
comparing sessions within the same day or between different days.
This finding suggests that CBF may provide a better outcome
measure than BOLD for studies demanding serial observations of
magnitude of change, for instance, in assessment of a drug
intervention in clinical trials.Acknowledgments
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